Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Increased Risk for Atrial Alternans in Rabbit Heart Failure: The Role of Ca2+/Calmodulin-Dependent Kinase II and Inositol-1,4,5-trisphosphate Signaling

Biomolecules(2023)10.3390/biom14010053Source: DataRank Database

Increased Risk for Atrial Alternans in Rabbit Heart Failure: The Role of Ca2+/Calmodulin-Dependent Kinase II and Inositol-1,4,5-trisphosphate Signaling is a research paper published in Biomolecules (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 0.18)OA: goldTopics (44)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Lothar A. Blatter ORCID,Giedrius Kanaporis ORCID

Live enrichment

PubMed:38254653 PMC:PMC10813785 OpenAlex:https://openalex.org/W4390459765

National Institutes of Health

Grant: HL057832

National Institutes of Health

Grant: HL132871

National Institutes of Health

Grant: HL134781

National Institutes of Health

Grant: HL155762

National Institutes of Health

Grant: HL164453

National Institutes of Health

Grant: 16GRNT30130011

NHLBI NIH HHS

Grant: R01 HL057832

NHLBI NIH HHS

Grant: R01 HL155762

NHLBI NIH HHS

Grant: R01 HL134781

NHLBI NIH HHS

Grant: R01 HL164453

NHLBI NIH HHS

Grant: R01 HL132871

National Institutes of Health

Grant: 5R01HL155762-04

IP3 receptor, NOX2 and calcium signaling domains in atrial physiology and pathophysiology

National Institutes of Health

Grant: 1R01HL132871-01A1

Pathophysiological Regulation of Atrial Alternans and Atrial Fibrillation

National Institutes of Health

Grant: 5R01HL164453-04

Atrial Excitation-Contraction Coupling, Calcium Signaling and Electro-Mechanical Alternans

National Institutes of Health

Grant: 5R01HL057832-03

CONTROL OF CA++- INDUCED CA++ RELEASE IN HEART

National Institutes of Health

Grant: 5R01HL134781-02

Pathophysiological Regulation of Atrial Myocyte Excitation-Contraction Coupling and Calcium Signaling

FWCI

0.18

Citation Percentile

0.6%

Citation Trend

2025

goldLicense: cc-by

journalhttps://www.mdpi.com/2218-273X/14/1/53/pdf?version=1703931857

publisherhttps://www.mdpi.com/2218-273X/14/1/53/pdf?version=1703931857

publisherhttps://www.mdpi.com/2218-273X/14/1/53/pdf

journalhttps://doi.org/10.3390/biom14010053

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38254653

Fields of Study

Cardiac electrophysiology and arrhythmiasAtrial Fibrillation Management and OutcomesIon channel regulation and function0303 health sciences03 medical and health sciences

MeSH Terms

Angiotensin IIAnimalsAtrial FibrillationCalmodulinHeart AtriaHeart FailureRabbitsInositol 1,4,5-TrisphosphatePeptide HormonesInositol 1,4,5-Trisphosphate ReceptorsCalcium-Calmodulin-Dependent Protein Kinase Type 2

Keywords

Internal medicineHeart failureEndocrinologyCalmodulinAtrial fibrillationAngiotensin IIChemistryCardiologyReceptorBiologyMedicineCalciumArrhythmiaAtriaAlternansCa2+/calmodulin-dependent Kinase IiInositol-trisphosphatePeptide HormonesCa<sup>2+</sup>/calmodulin-dependent kinase IIInositol 1,4,5-TrisphosphateMicrobiologyQR1-502ArticleAnimalsInositol 1,4,5-Trisphosphate ReceptorsRabbitsHeart AtriaCalcium-Calmodulin-Dependent Protein Kinase Type 2

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being